Join
Live feed
·
NEWSReleasevia Quantisnow
Regentis Biomaterials Ltd. logo

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

ByQuantisnow·Wall Street's wire, on your screen.
RGNT· Regentis Biomaterials Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RGNT (Regentis Biomaterials Ltd.) and more on Quantisnow.

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon | Quantisnow